Mengyang Di, MD, PhD

Dr. Mengyang Di is a hematologist-oncologist specializing in lymphoma and chronic lymphocytic leukemia diagnosis, treatment and research, including clinical trials. A graduate of Peking Union Medical College and the Chinese University of Hong Kong (PhD, Epidemiology) Dr. Di also completed a residency in internal medicine at Brown University and a fellowship in hematology and medical oncology at Yale University.

Dr. Di is interested in examining novel therapies or new combinations of drugs for lymphoma in clinical trials and has contributed extensively to research in the field. Her research has also been focused on assessing lymphoma outcomes in real-world practice, identifying challenges (e.g., practice- or policy-level factors) contributing to suboptimal outcomes, and designing interventions to improve care quality and outcomes. She has received multiple Young Investigator Awards from the Chinese American Hematologist and Oncologist Network (CAHON) and is board-certified in internal medicine, hematology and medical oncology by the American Board of Internal Medicine.